ABBOTT PARK, Ill., Jan. 26, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received CE Mark for two new uses of its Panbio™ COVID-19 Ag Rapid Test Device for the detection of the ...

Abbott has received new COVID-19 diagnostic approvals in Europe for its rapid Panbio antigen test, clearing it for self-performed screening under supervision as well as widespread use by people who ...

Abbott Laboratories ABT recently received the CE Mark for its Panbio COVID-19 Antigen Self-Test for sale directly to consumers. The test, which delivers results in a few minutes, can be used to detect ...

Even as Abbott continues to anticipate a steep drop-off in its COVID-19 testing sales boom—and recently updated its financial projections for the year to reflect that—testing demand has yet to ...

OTTAWA, Oct 6 (Reuters) - Canada said on Tuesday that it had signed a deal with Abbott (ABT.N), opens new tab to purchase up to 20.5 million Panbio COVID-19 antigen tests as Health Canada approved the ...

- Philippines scales its testing capability with two Abbott tests – a quick, patient-friendly rapid antigen test and lab-based quantitative antibody test - The Abbott Panbio™ COVID-19 Antigen Rapid ...

The rapid-response, point-of-care tests should trim the long lines seen at some of the country's testing sites. Panbio is an antigen test that can produce results on the spot in 20 minutes. It is also ...

In a recent study posted to the Lancet preprint* server, researchers assessed the utility of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) rapid antigen testing (RAT) for patient triage ...

In a recent study published on the preprint server medRxiv*, researchers analyze commercially available rapid antigen tests to evaluate their analytical sensitivity and specificity, as well as ...

OTTAWA, Oct 6 (Reuters) - Canada said on Tuesday that it had signed a deal with Abbott Rapid Diagnostics to purchase up to 20.5 million Panbio COVID-19 Antigen rapid tests. Health Canada has also ...